Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target 3.4

Cardiovascular Diagnosis and Therapy

Volumn 9, Issue 2, 2019, Pages 140-149

  Wou, Constance ^a   Unwin, Nigel ^a   Huang, Yadi ^b   Roglic, Gojka ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b International Diabetes Federation   (Belgium)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cardiovascular diseases (CVD); Diabetes mellitus; Mortality; Premature

Indexed keywords

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE BURDEN; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH INCOME COUNTRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE INCOME COUNTRY; MORTALITY RATE; PREMATURE MORTALITY; PREVALENCE; REVIEW; RISK FACTOR; SUSTAINABLE DEVELOPMENT; SYSTEMATIC REVIEW (TOPIC); WORLD HEALTH ORGANIZATION;

EID: 85068938010     PISSN: 22233652     EISSN: 22233660     Source Type: Journal    
DOI: 10.21037/cdt.2018.09.04     Document Type: Review

References (35)

1. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151-210.
2. World Health Organization. Global status report on noncommunicable diseases 2014. 2014.
3. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: Realistic estimates for the year 2000. Diabetes Care 2005;28:2130-5.
4. World Health Organization (WHO). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. 2013.
5. United Nations. Transforming our world: The 2030 Agenda for Sustainable Development. Available online: Https://sustainabledevelopment.un.org/post2015/transformingourworld/publication
6. International Diabetes Federation. Diabetes and cardiovascular disease. 2016.
7. International Diabetes Federation. IDF Diabetes Atlas 5th edition. 2011.
8. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387:1513-30.
9. Su SY, Lee WC, Chen TT, et al. An evaluation of the 25 by 25 goal for premature cardiovascular disease mortality in Taiwan: An age-period-cohort analysis, population attributable fraction and national population-based study. Heart Asia 2017;9:e010905.
10. Norheim OF, Jha P, Admasu K, et al. Avoiding 40% of the premature deaths in each country, 2010-30: Review of national mortality trends to help quantify the UN sustainable development goal for health. Lancet 2015;385:239-52.
11. González-Pier E, Barraza-Lloréns M, Beyeler N, et al. Mexico's path towards the Sustainable Development Goal for health: An assessment of the feasibility of reducing premature mortality by 40% by 2030. Lancet Glob Health 2016;4:e714-25.
12. Ordunez P, Prieto-Lara E, Pinheiro Gawryszewski V, et al. Premature Mortality from Cardiovascular Disease in the Americas - Will the Goal of a Decline of "25% by 2025" be Met? PLoS One 2015;10:e0141685.
13. Li Y, Zeng X, Liu J, et al. Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030? BMC Med 2017;15:132.
14. Roth GA, Nguyen G, Forouzanfar MH, et al. Estimates of global and regional premature cardiovascular mortality in 2025. Circulation 2015;132:1270-82.
15. Kontis V, Mathers CD, Bonita R, et al. Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: A modelling study. Lancet Glob Health 2015;3:e746-57.
16. Kontis V, Mathers CD, Rehm J, et al. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: A modelling study. Lancet 2014;384:427-37.
17. Cobiac LJ, Scarborough P. Translating the WHO 25×25 goals into a UK context: The PROMISE modelling study. BMJ Open 2017;7:e012805.
18. Sacco RL, Roth GA, Reddy KS, et al. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation. Circulation 2016;133:e674-90.
19. Santosa A, Rocklöv J, Högberg U, et al. Achieving a 25% reduction in premature non-communicable disease mortality: The Swedish population as a cohort study. BMC Med 2015;13:65.
20. GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016. Lancet 2017;390:1423-59.
21. Interantional Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017. 2017.
22. Butala NM, Johnson BK, Dziura JD, et al. Decade-long trends in mortality among patients with and without diabetes mellitus at a major academic medical center. JAMA Intern Med 2014;174:1187-8.
23. Tsujimoto T, Kajio H, Sugiyama T. Favourable changes in mortality in people with diabetes: US NHANES 1999-2010. Diabetes Obes Metab 2018;20:85-93.
24. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: A population-based study. Diabetologia 2013;56:2601-8.
25. Faerch K, Carstensen B, Almdal TP, et al. Improved Survival Among Patients With Complicated Type 2 Diabetes in Denmark: A Prospective Study (2002-2010). J Clin Endocrinol Metab 2014;99:E642-6.
26. Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ. Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010. Diabetes Care 2014;37:2579-86.
27. Gregg EW, Gu Q, Cheng Y, et al. Mortality Trends in Men and Women with Diabetes, 1971 to 2000. Ann Intern Med 2007;147:149-55.
28. Read SH, Kerssens JJ, McAllister DA, et al. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia 2016;59:2106-13.
29. Aspelund T, Gudnason V, Magnusdottir BT, et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One 2010;5:e13957.
30. Björck L, Rosengren A, Bennett K, et al. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009;30:1046-56.
31. Bruthans J, Cífková R, Lánská V, et al. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007. Eur J Prev Cardiol 2014;21:829-39.
32. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
33. Unal B, Sözmen K, Arik H, et al. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health 2013;13:1135.
34. Saidi O, Ben Mansour N, O'Flaherty M, et al. Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS One 2013;8:e63202.
35. Cheng J, Zhao D, Zeng Z, et al. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health 2009;9:30.